165 related articles for article (PubMed ID: 32852057)
21. Effects of Kampo medicines on MDR-1-mediated multidrug resistance in human hepatocellular carcinoma HuH-7/PTX cells.
Hyuga S; Shiraishi M; Hori A; Hyuga M; Hanawa T
Biol Pharm Bull; 2012; 35(10):1729-39. PubMed ID: 23037162
[TBL] [Abstract][Full Text] [Related]
22. Design, synthesis and biological evaluation of seco-DSP/DCK derivatives reversing P-glycoprotein-mediated paclitaxel resistance in A2780/T cells.
Wang W; Wan Q; Li M; Qu F; Liu H; Chen Y
Eur J Med Chem; 2023 Mar; 250():115218. PubMed ID: 36871374
[TBL] [Abstract][Full Text] [Related]
23. Reversal of P-glycoprotein-mediated multidrug resistance in vitro by AV200, a new ardeemin derivative.
Méndez-Vidal C; Quesada AR
Cancer Lett; 1998 Oct; 132(1-2):45-50. PubMed ID: 10397452
[TBL] [Abstract][Full Text] [Related]
24. Antitumor agents. 293. Nontoxic dimethyl-4,4'-dimethoxy-5,6,5',6'-dimethylenedioxybiphenyl-2,2'-dicarboxylate (DDB) analogues chemosensitize multidrug-resistant cancer cells to clinical anticancer drugs.
Hung HY; Ohkoshi E; Goto M; Bastow KF; Nakagawa-Goto K; Lee KH
J Med Chem; 2012 Jun; 55(11):5413-24. PubMed ID: 22612652
[TBL] [Abstract][Full Text] [Related]
25. 5-(3,4,5-trimethoxybenzoyl)-4-methyl-2-(p-tolyl) imidazol (BZML) targets tubulin and DNA to induce anticancer activity and overcome multidrug resistance in colorectal cancer cells.
Bai Z; Liu X; Guan Q; Ding N; Wei Q; Tong B; Zhao M; Zhang W; Ma L
Chem Biol Interact; 2020 Jan; 315():108886. PubMed ID: 31682804
[TBL] [Abstract][Full Text] [Related]
26. Caffeic Acid Attenuates Multi-Drug Resistance in Cancer Cells by Inhibiting Efflux Function of Human P-glycoprotein.
Teng YN; Wang CCN; Liao WC; Lan YH; Hung CC
Molecules; 2020 Jan; 25(2):. PubMed ID: 31936160
[No Abstract] [Full Text] [Related]
27. Bipiperidinyl derivatives of 23-hydroxybetulinic acid reverse resistance of HepG2/ADM and MCF-7/ADR cells.
Zhang DM; Li YJ; Shu C; Ruan ZX; Chen WM; Yiu A; Peng YH; Wang J; Lan P; Yao Z; Fung KP; Fu LW; Chen ZS; Ye WC
Anticancer Drugs; 2013 Jun; 24(5):441-54. PubMed ID: 23466650
[TBL] [Abstract][Full Text] [Related]
28. Synthesis and biological evaluation of thiophenylbenzofuran derivatives as potential P-glycoprotein inhibitors.
Hung CC; Chen CY; Wu YC; Huang CF; Huang YC; Chen YC; Chang CS
Eur J Med Chem; 2020 Sep; 201():112422. PubMed ID: 32569926
[TBL] [Abstract][Full Text] [Related]
29. Tetrandrine Interaction with ABCB1 Reverses Multidrug Resistance in Cancer Cells Through Competition with Anti-Cancer Drugs Followed by Downregulation of ABCB1 Expression.
Liao D; Zhang W; Gupta P; Lei ZN; Wang JQ; Cai CY; Vera AA; Zhang L; Chen ZS; Yang DH
Molecules; 2019 Nov; 24(23):. PubMed ID: 31801248
[TBL] [Abstract][Full Text] [Related]
30. Reversal of P-glycoprotein-mediated multidrug resistance by novel curcumin analogues in paclitaxel-resistant human breast cancer cells.
Gao L; Zhao P; Li Y; Yang D; Hu P; Li L; Cheng Y; Yao H
Biochem Cell Biol; 2020 Aug; 98(4):484-491. PubMed ID: 31967866
[TBL] [Abstract][Full Text] [Related]
31. Zhankuic Acids A, B and C from
Teng YN; Wang YH; Wu TS; Hung HY; Hung CC
Biomolecules; 2019 Nov; 9(12):. PubMed ID: 31766413
[No Abstract] [Full Text] [Related]
32. Multidrug resistance reversal agent, NSC77037, identified with a cell-based screening assay.
Susa M; Choy E; Yang C; Schwab J; Mankin H; Hornicek F; Duan Z
J Biomol Screen; 2010 Mar; 15(3):287-96. PubMed ID: 20150589
[TBL] [Abstract][Full Text] [Related]
33. Exploration of 1,2,3-triazole-pyrimidine hybrids as potent reversal agents against ABCB1-mediated multidrug resistance.
Wang B; Zhao B; Chen ZS; Pang LP; Zhao YD; Guo Q; Zhang XH; Liu Y; Liu GY; Hao-Zhang ; Zhang XY; Ma LY; Liu HM
Eur J Med Chem; 2018 Jan; 143():1535-1542. PubMed ID: 29126726
[TBL] [Abstract][Full Text] [Related]
34. Identification of two distinct intracellular sites that contribute to the modulation of multidrug resistance in P388/ADR cells expressing P-glycoprotein.
Mayer LD; Lim KT; Hartley D
J Exp Ther Oncol; 2002; 2(2):107-20. PubMed ID: 12415627
[TBL] [Abstract][Full Text] [Related]
35. The effect and mechanistic study of encequidar on reversing the resistance of SW620/AD300 cells to doxorubicin.
Zhang H; Bian S; Xu Z; Gao M; Wang H; Zhang J; Zhang M; Ke Y; Wang W; Chen ZS; Xu H
Biochem Pharmacol; 2022 Nov; 205():115258. PubMed ID: 36179932
[TBL] [Abstract][Full Text] [Related]
36. Curcumin reverses doxorubicin resistance in colon cancer cells at the metabolic level.
Zhang N; Gao M; Wang Z; Zhang J; Cui W; Li J; Zhu X; Zhang H; Yang DH; Xu X
J Pharm Biomed Anal; 2021 Jul; 201():114129. PubMed ID: 34000577
[TBL] [Abstract][Full Text] [Related]
37. By inhibiting Src, verapamil and dasatinib overcome multidrug resistance via increased expression of Bim and decreased expressions of MDR1 and survivin in human multidrug-resistant myeloma cells.
Tsubaki M; Komai M; Itoh T; Imano M; Sakamoto K; Shimaoka H; Takeda T; Ogawa N; Mashimo K; Fujiwara D; Mukai J; Sakaguchi K; Satou T; Nishida S
Leuk Res; 2014 Jan; 38(1):121-30. PubMed ID: 24239173
[TBL] [Abstract][Full Text] [Related]
38. Intracellular levels of two cyclosporin derivatives valspodar (PSC 833) and cyclosporin a closely associated with multidrug resistance-modulating activity in sublines of human colorectal adenocarcinoma HCT-15.
Uchiyama-Kokubu N; Watanabe T; Cohen D
Jpn J Cancer Res; 2001 Oct; 92(10):1116-26. PubMed ID: 11676863
[TBL] [Abstract][Full Text] [Related]
39. Taxol Analogues Exhibit Differential Effects on Photoaffinity Labeling of β-Tubulin and the Multidrug Resistance Associated P-Glycoprotein.
Yang CH; Wang C; Ojima I; Horwitz SB
J Nat Prod; 2018 Mar; 81(3):600-606. PubMed ID: 29517223
[TBL] [Abstract][Full Text] [Related]
40. Syl611, a novel semisynthetic taxane derivative, reverses multidrug resistance by p-glycoprotein inhibition and facilitating inward transmembrane action.
Zhang Y; Li H; Wang H; Su F; Qu R; Yin D; Dai J; Li Y; Chen X
Cancer Chemother Pharmacol; 2010 Oct; 66(5):851-9. PubMed ID: 20052473
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]